RecruitingNot Applicable

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

China80 participantsStarted 2024-07-02

Plain-language summary

This study is a real-world study to observe the role of adjuvant radiotherapy in locally advanced recurrent high-risk thyroid cancer. The study included thyroid cancer that requires adjuvant radiotherapy to increase local control rate, excluding undifferentiated cancer. Local-regional recurrence free survival is the primary endpoint of the study.

Who can participate

Age range14 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The surgery did not achieve R0 resection;
✓. After neoadjuvant therapy;
✓. Pathological types with poor prognosis, such as poorly differentiated cancer, CASTLE, etc;
✓. Thyroid cancer with obvious extracapsular invasion, invading important structures such as the esophagus, trachea, and recurrent laryngeal nerve, requiring adjuvant radiotherapy;
✓. For patients with distant metastasis, researchers need to determine the value of local treatment;

What they're measuring

LRRFS

Timeframe: 5 years

Trial details

NCT IDNCT06524167

SponsorFudan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2031-06-30

Contact for this trial

Naisi Huang

86-021-64175590 huangnsisi@fduan.edu.cn

View on ClinicalTrials.gov More Thyroid Cancer trials